STOCK TITAN

Orhub's Story Proves the Power of a Winning Culture

ORHub has made strides in improving hospital relationships with biotech firms, focusing on enhancing surgical experiences.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Rhea-AI Summary

ORHub has made strides in improving hospital relationships with biotech firms, focusing on enhancing surgical experiences. The company recently completed its FutureORTM software, which aims to streamline operations in hospital operating rooms. Additionally, ORHub is pursuing an acquisition of PUR Biologics, known for its innovative bone regeneration and pain management products. Plans for rebranding and strengthening public market communications are underway, with a vision to develop a Digital Health and Regenerative Therapeutic division. ORHub's leadership expresses optimism about future growth and shareholder value.

Loading...
Loading translation...

Positive

  • Completion of FutureORTM software aimed at operational efficiency in hospitals.
  • Pursuing acquisition of PUR Biologics, expanding product portfolio and addressing chronic pain.
  • Ongoing efforts to reduce debt and enhance public communications.

Negative

  • None.
Argus Session date unavailable
-11.70% session move Open Argus
Details

News Market Reaction – ORHB

The recorded move for ORHB in the trading session of this news was -11.70%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

IRVINE, CA / ACCESSWIRE / March 14, 2022 / An Important message from the Chairman & CEO

Dear Shareholders,

It is an exciting time for ORHub. Our vision for the Company began in the operating room where we identified opportunities to improve the business relationship shared between hospital and medical device / biotech companies that ultimately impact a patient's surgical experience. Our mindset on Changing Business for GoodTM will not waiver and will continue to guide our business design and strategy, while remaining focused on helping deliver sustainable healthcare and future innovation.

ORHub has made significant progress on all fronts: removing distractions, continuing relevant filings, reducing debt, and ongoing preparation for an audit. We have made a significant investment to develop and recently completed the long-awaited FutureORTM software, designed to deliver efficiency for hospital operating rooms and participating biological & medical device vendors. FutureORTM enables new digital processes to increase payment speed with these manufacturers, while controlling cost and accuracy for the hospitals. ORHub is in continued discussions to acquire, merge, or partner with strategic businesses that fit our vision in healthcare technologies. Our goal with these transactions, is to achieve fast and profitable growth using current product and opportunities with highly scalable potential with our market channels and leverage.

ORHub has entered a LOI and is pursuing an acquisition of PUR Biologics, an ortho-biologic company. PUR brings a product portfolio for bone regeneration and a patent portfolio including interests in regenerating mature hyaline cartilage, skin health & aesthetics. PUR's research explores novel changes to how we address chronic pain, osteoarthritis, and a potentially significant neurological application.

Along with our new website, which is being prepared by branding professionals, ORHub is reestablishing its social media presence, and will steadily increase public market and investor communications.

As we shape the Company's future operations to include a Digital Health and Regenerative Therapeutic division, we anticipate a "new corporate name" will soon be launched to support our significant progress and to best represent our evolving Company.

We are excited about the future of ORHub and look forward to increasing your share value. Thank you for your support.

Sincerely,

CJ Wiggins

Chairman & CEO

www.ORHub.com

SOURCE: ORHUB, Inc.



View source version on accesswire.com:
https://www.accesswire.com/692869/Orhubs-Story-Proves-the-Power-of-a-Winning-Culture

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What recent software has ORHub completed?

ORHub has completed the FutureORTM software to enhance operational efficiency in hospital operating rooms.

What acquisition is ORHub pursuing?

ORHub is pursuing the acquisition of PUR Biologics, focusing on bone regeneration and chronic pain management.

What new division is ORHub planning to develop?

ORHub plans to develop a Digital Health and Regenerative Therapeutic division.

How is ORHub enhancing its public communications?

ORHub is reestablishing its social media presence and increasing investor communications.

What is ORHub's vision moving forward?

ORHub's vision includes changing the business landscape for good and delivering sustainable healthcare innovations.

Keep reading